← All stories
Markets
STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study

A Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.
Covered by 1 outlet
All coverage · 1 article